Notes d’épisode
In this episode of Data in Biotech, Ross Katz sits down with Kyle Smith and Jacob Mayer from Aprecia Pharmaceuticals to explore how 3D printing is transforming pharmaceutical manufacturing. They dive into the unique binder jetting process, in-cavity printing, and how real-time data and automation are enabling agile, scalable, and precise drug production. Discover how Aprecia's approach is changing the game for clinical trials and personalized medicine.
What you'll learn in this episode:
>> How Aprecia developed the world’s first FDA-approved 3D printed drug
>> Why binder jetting stands…
Site web: corrdyn.com

